Here are nine key points:
1. Xtant’s quarterly revenues hit $21 million, a 3 percent decrease from the same period in 2015.
2. The company’s core recurring revenue rose to $20.5 million, a 6.8 percent increase from $19.2 million in the same period a year prior.
3. Xtant’s gross profit increased to $14.1 million.
4. Gross margins increased to 67.2 percent, compared to pro forma 63.4 percent in the first quarter of 2015.
5. Xtant experienced consolidated EBITDA loss of $145,000 for the first quarter of 2016.
6. The company saw a consolidated net loss of $5.6 million, compared to $6 million in quarter one 2015.
7. Sales and marketing expenses increased to $10.5 million from $9.6 billion the same quarter last year.
8. General and administrative expenses decreased to $3.5 million from $3.9 million in quarter one 2015.
9. Cash on hand hit $4.7 million by March 31, 2016.
More articles on devices:
FDA clears First Ray’s Stealth Staple System — 5 highlights
Medtronic names Karen Parkhill EVP, CFO: 5 key notes
Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
